New Frontier Data, the global cannabis industry authority in intelligence reporting and data analysis, and Steep Hill, the leader in cannabis testing and scientific analytics worldwide, have created a strategic alliance to offer their technology and scientific expertise to governmental agencies in European Union member countries. The New Frontier Data - Steep Hill alliance will focus on assisting local, regional and country level regulators and legislators who are working on (or interested in exploring) the development of the cannabis industry. Both companies have extensive experience with the opportunities and the potential pitfalls regulators have encountered in the United States, Canada, and other countries, and consequently understand the requisite pillars of a safe, healthy and functional cannabis industry. The companies are perfectly aligned to inform, assess, and help lay the foundation for a healthy and responsible global cannabis industry across the E.U. based on vetted and statistically meaningful socio-economic data, combined with accurate cannabis scientific testing data and technologies.
|
|||
“Dozens of countries around the globe are considering cannabis decriminalization or legalization, and many in Europe are now assessing establishing a medical market and cannabis-focused scientific research. The strategic relationship between New Frontier Data and Steep Hill - two unbiased and highly experienced third-party information providers - presents stakeholders and policy makers with critical historical data needed to guide and educate their decision making as they explore, or move forward into, the cannabis space,” said New Frontier Data Founder & CEO Giadha Aguirre de Carcer.
“In working together in the newly-emerging cannabis market across Europe, the goal of our strategic alliance with New Frontier Data is to improve regulators’ ability to address the demand for medical cannabis throughout Europe, with sound practices that offer transparency, traceability and accountability in newly emerging medical cannabis markets”, said Jmîchaeĺe Keller, CEO of Steep Hill.
For more information regarding this strategic alliance contact: Gretchen Gailey at 202-489-3821, [email protected]
About New Frontier Data:
New Frontier Data provides objective, rigorous and comprehensive analysis and reporting for the nascent and underserved cannabis industry. New Frontier’s data and reports have been cited in over 65 countries around the world to inform industry leaders. New Frontier Data, the premiere Big Data shop in the sector looks beyond the plant cultivation and distribution, to raise the industry bar and improve visibility into what will inevitably soon be a mature and more complex industry. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. and has additional offices in Denver.
New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry. For more information about New Frontier Data please visit: www.newfrontierdata.com.
About Steep Hill:
Steep Hill is the world’s leading cannabis science and technology company with significant footprints in lab testing, research and development, licensing, genetics and remote testing. No other company brings all of these sectors into one highly synergistic whole. Steep Hill’s foundation was built on testing and analyzing medical and recreational marijuana to ensure compliance with public safety standards. In 2008, Steep Hill opened the first commercial cannabis lab in the United States and has been on the cutting edge since its inception. Steep Hill is expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information about Steep Hill please visit: www.steephill.com.
####
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/14fe4d9e-3d50-4cf7-b18b-362ee9767dc5
Gretchen Gailey New Frontier Data 202-489-3821 [email protected]


Amazon Explores AI Content Marketplace With Media Publishers
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



